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Objectives and Hypothesis: Our objectives were to characterize the quality of acute sinusitis care and to identify non-
clinical factors associated with antibiotic use for acute sinusitis. We hypothesized that we would identify provider-level fac-
tors associated with antibiotic use.
Study Design: Retrospective cohort at a single academic institution.
Methods: We developed and clinically annotated an administrative dataset of adult patients diagnosed with acute sinusi-
tis between January 1, 2005, and December 31, 2006. We used identify factors associated with receipt of antibiotics.
Results: We find that 66.0% of patients with mild symptoms of short duration are given antibiotics, and that nonclinical
factors, including the individual provider, the provider’s specialty, and the presence of a medical trainee, significantly influ-
ence antibiotic use. Relative to internal medicine providers, family medicine providers use fewer antibiotics, and emergency
medicine providers use more antibiotics for acute sinusitis.
Conclusions: Antibiotics continue to be overused for patients with mild acute sinusitis of short duration. Nonclinical
characteristics, including the individual provider, the provider’s specialty, and the presence of a medical trainee, significantly
influence use of antibiotics for acute sinusitis.
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INTRODUCTION
Sinusitis is one of the most common conditions treated
by primary care providers.1–3 As with other upper respira-
tory infections (URIs), sinusitis is usually a viral infection.
Despite the lack of efficacy, antibiotics are pervasively over-
used for sinusitis, resulting in widespread antibiotic resist-
ance.4,5 Decreasing antibiotic use for uncomplicated
sinusitis is an important focus of antimicrobial stewardship.
A few studies have examined specific factors related
to antibiotic use, including provider specialty,6 visit
duration,7 and resident physician provider.6 However,
these studies were based on population-based surveys
that include minimal clinical data. Without clinical data,
it can be difficult to discern illness duration, symptom
severity, or relevant comorbidities that may impact the
provider’s decision to prescribe antibiotics.
In order to identify factors that may contribute to
antibiotic overuse for acute sinusitis, we designed an
observational cohort based on administrative data with
clinical details extracted from the electronic medical
record (EMR). Our first objective was to broadly charac-
terize the quality of care for patients with acute sinusitis
at initial diagnosis using the American Academy of Oto-
laryngology–Head and Neck Surgery (AAO–HNS) Clini-
cal Practice Guideline: Adult Sinusitis as a benchmark.
Our second objective was to identify nonclinical factors
associated with antibiotic use.
MATERIALS AND METHODS
Patient Identification
We identified adult patients diagnosed with acute or
chronic sinusitis or upper respiratory infection (URI) (Interna-
tional Classification of Diseases, 9th edition [ICD-9] codes
461.x, 473.x, 460, 465) between January 1, 2005, and December
31, 2006, within the University of Michigan Health Care Sys-
tem, Ann Arbor, Michigan. These patients were identified
through our institution’s robust Clinical Research and Health
Information Exchange (data repository), which contains demo-
graphic, clinical, and professional fee billing information. We
included patients from the emergency department or primary
care practices, together with geriatrics, family medicine, and
internal medicine, and excluded patients from subspecialty
practices. We excluded patients with concurrent pharyngitis,
otitis media, acute tonsillitis, bronchitis, strep throat (ICD-9
codes 462, 034.0, 463–464, 381.0–381.4, 382, 466, 490, 491.21).
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To minimize confounding by chronic sinusitis, we excluded
patients with a visit for sinusitis or URI in the preceding 365
days, and patients who may have not have had access to care
(no visit to a primary care provider in the preceding 365 days).
We created variables to describe the provider from the
visit corresponding to cohort inception, including gender,
department affiliation, medical specialty, degree type (Doctor of
Medicine, Doctor of Osteopathic Medicine, Bachelor of Medicine
Bachelor of Surgery, or midlevel provider) and years in practice
(reference year5 2006).
Electronic MEdical Record Search Engine
We clinically annotated the dataset by reviewing EMR
documentation from the date of cohort inception using
EMERSE (Electronic Medical Record Search Engine) soft-
ware.8,9 This internally developed Web-based application pro-
vides a simple interface for searching the EMR with a bundle of
words and phrases for variables of interest. For example, we
created EMERSE search bundles for each of the three major
symptoms of sinusitis (rhinorrhea, nasal obstruction, facial
pressure) using medical and lay terms3 (Figure 1). Each bundle
was tested and modified in an iterative fashion. The finalized
bundle facilitated rapid and thorough review of the EMR by
highlighting text matching one or more of the terms in the
search bundle. For example, “pain” was in the facial pressure
bundle, and EMERSE highlighted the word “pain” regardless of
the textual context (“patient reports facial pain,” “patient denies
facial pain,” “sinuses are painful”), allowing the reviewer to
quickly identify text for reading and coding.
We created additional EMERSE search bundles as needed
to facilitate identification and coding of other clinical data
points described in the protocol below.
Protocol for EMR Review and Coding Clinical
Variables
We developed an explicit protocol to code variables of
interest, as documented in the provider’s narrative documenta-
tion of the sinusitis visit. We coded symptoms/signs of sinusitis
and patient-reported fever as present or absent. We coded
symptom duration as the number of days from symptom onset
and systematically coded nonspecific references to symptom
duration (few53; several5 7; week and a half5 10; many5 11;
couple weeks5 14; few weeks521; several weeks5 28; last
month530; couple months5 60; several months5 90). We iden-
tified patients with possible severe illness with indicator varia-
bles for pain (any pain except that characterized as mild or
minimal), documented fever (temperature>1018F), or immuno-
compromised status. We coded the provider’s impression of
sinusitis etiology in three categories: bacterial, nonbacterial
(includes viral and noninfectious causes), and undocumented.
We extracted recommendations for nonprescription therapy
(analgesics and decongestants) and prescription therapy (nasal
steroid sprays and antibiotics). We coded antibiotic use in four cat-
egories: 1) observation without antibiotics, 2) continue current
antibiotic, 3) antibiotic prescribed, and 4) wait-and-see instruc-
tions given with an antibiotic prescription. We coded provider spe-
cialty and the presence of a medical trainee (medical student or
resident). We reviewed subsequent encounters to determine if 1)
an antibiotic was prescribed after an initial trail of observations,
or 2) if the antibiotic type was changed within 5 days.
We tested the protocol on the first 100 patients. Team
members independently coded the cases and then met to review
coding and revise the protocol to ensure data capture and uni-
form coding across team members. Thereafter, study team mem-
bers worked in pairs. Each member independently reviewed the
EMR, and the pair met weekly to compare codes. The entire
team met weekly to resolve discrepancies.
Statistical Analysis
Because we were focused on antibiotic prescription at initial
diagnosis, we excluded from statistical analysis 30/1,302 patients
who were advised to “continue current antibiotic” prescribed prior
to the inception visit date. We analyzed the remainder of the cohort
(1,272) analysis. In order to characterize the quality of sinusitis
care institution, we calculated descriptive statistics to describe
demographic and clinical characteristics andmedical treatment for
the remaining cohort. We determined the proportion of patients
who were eligible for observation by excluding from the denomina-
tor patients with documented fever, pain, or immune suppression.
To identify clinical and nonclinical factors associated with
antibiotic use, we performed bivariable, multivariable, and mul-
tilevel analyses using receipt of antibiotics versus observation
as the outcome of interest. For this outcome, we compared
patients who were prescribed antibiotics versus those who were
not prescribed antibiotics, or who were given wait-and-see
instructions with an antibiotic prescription. Bivariable analyses
were performed using logistic regression with P<0.05 as the
level of significance.
We developed the multivariable model by including in the
full model all variables with P<0.2 on bivariable analysis. To
check for confounding, the nonsignificant variables were indi-
vidually forced back into the model using a 15% change in the
parameter estimate as the retention criterion. We developed a
two-level generalized linear mixed model, logistic regression, to
account for the nested study design and to test our hypothesis.
The patient was the primary unit of analysis. A total of 1,272
patients were nested in 153 providers. The provider level varia-
bles were specialty, gender, and years in practice. The patient
level control variables were gender, age, race, type of insurance,
and presence of a medical trainee. The patient level predictor
variables were nasal obstruction, rhinorrhea, pain, facial pres-
sure, symptom duration, and presumed etiology.
First, we examined the initial effect sizes of all provider level
variables, followed by all patient-level variables. Second, we exam-
ined the full model with variables from both levels as fixed effects.
We used a cutoff of P0.2 to determine which variables to retain
in subsequent modeling. We also looked for significant interac-
tions between patient symptoms (nasal obstruction, rhinorrhea,
pain, facial pressure) and between provider specialty and patient
symptoms using P0.1 as the cutoff. All statistical analyses were
performed with SAS 9.3 (SAS Institute, Inc., Cary, NC).
RESULTS
We identified 7,402 adults with sinusitis or URI
diagnosed in a primary care or emergency department
Fig. 1. Electronic Medical Record Search Engine search bundles
for each of the three major symptoms of sinusitis.
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setting. We excluded patients who might have had pre-
existing sinusitis based on prior visits for sinusitis or
without clear access to care (1,951). We excluded
patients with URI (4,024) and reviewed the EMR for the
remaining patients with sinusitis (1,427). We excluded
patients with ineligible encounter type (e.g., telephone
notes) or absent documentation (11). We excluded
patients diagnosed with chronic sinusitis (114) because
they will be described in a separate manuscript. The
remaining patients with acute sinusitis (1,302) were the
focus of this study.
Review of the EMR found that 30 of these 1,302
patients were advised to “continue current antibiotic.” In
some cases, the documentation indicates the current
antibiotic was for a recently diagnosed respiratory infec-
tion; other cases are unclear. Because the decision to
prescribe antibiotics at the initial diagnosis of acute
sinusitis is the primary outcome measure of this study,
we excluded these 30 patients from analysis, leaving
1,272 patients for statistical analysis (Figure 2).
Patient and Provider Characteristics
Most of the patients were women (73.0%), with a
mean age across men and women of 44.5 years. Consist-
ent with our regional demographics, most patients were
white (88.8%), with private insurance (86.4%). Similar
proportions of patients had symptoms 10 days (44.3%)
versus<10 days (40.4%), and the rest were undocu-
mented (15.3%). Symptoms of facial pressure (76.7%),
rhinorrhea (74.8%), and nasal obstruction (66.0%) were
common. The majority of patients (81.3%) reported at
least two of these three symptoms, although 3.4% of
patients had none. Pain (41.0%) and patient-reported
fever (20.1%) were common, but documented fever (0.6%)
was very uncommon. Documentation of the presumed eti-
ology of the acute sinusitis, whether viral or bacterial,
was lacking in the majority of records (76.7% undocu-
mented). Medical student or resident trainees were pres-
ent at a minority of patient visits (11.6%) (Table I).
Analysis of the providers found similar proportions
of internal medicine (42.8%) and family medicine
Fig. 2. Flow chart depicting identification of patients for inclusion
in analytic dataset.
TABLE I.
Patient Characteristics for Adult Acute Sinusitis Visits, Institution.
Characteristic (N5 1272) N (%)
Age, mean (SD) 44.5 (13.9)
Female 928 (73.0)
*Race (n51227)
White 1,089 (88.8)
non-White 138 (11.3)
*Insurance (n5 1271)
Private 1098 (86.3)
Public or uninsured 173 (13.6)
Symptom duration
Undocumented 194 (15.3)
< 10 days 514 (40.4)
 10 days 564 (44.3)
Symptoms
Facial pressure 975 (76.7)
Rhinorrhea 952 (74.8)
Nasal obstruction 839 (66.0)
Pain 521 (41.0)
Patient-reported fever 256 (20.1)
Documented fever 8 (0.6)
Immunocompromised 14 (1.1)
Penicillin allergy 223 (17.5)
Etiology
Undocumented 975 (76.7)
Nonbacterial 208 (16.4)
Bacterial 89 (7.0)
Trainee present 148 (11.6)
*Numbers do not total 100% because of missing observations.
SD5 standard deviation.
TABLE II.
Provider Characteristics for Adult Acute Sinusitis Visits, UMHS.
Characteristic (N5 153) N (%)
Provider specialty
Internal medicine 65 (42.8)
Family medicine 61 (39.9)
Emergency medicine 27 (17.7)
Female 81 (52.9)
Degree
MD 139 (90.9)
DO 6 (3.9)
Midlevel provider 6 (3.9)
MBBS 2 (1.3)
Years in practice, mean (SD) 11.6 (8.1)
DO5Doctor of Osteopathic Medicine; MBBS5Bachelor of Medicine
Bachelor of Surgery; MD5Doctor of Medicine; SD5 standard deviation;
UMHS5University of Michigan Health System.
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(39.9%) and fewer emergency medicine providers
(17.7%). Most were women (52.9%), with a mean of 11.6
years in practice (Table II).
Medical Care
Medical therapy included decongestants (40.3%),
nasal corticosteroids (12.3%), and analgesics (11.2%).
Antibiotic prescriptions were given to 86.1% patients
overall, including 79.0% who were given a prescription
for immediate use and an additional 7.1% who were given
a prescription with wait-and-see instructions. The
remaining 13.9% of patients were not given antibiotics.
However, for the analysis of antibiotic use versus observa-
tion, we defined observation to include the 7.1% of
patients given a prescription with wait-and-see instruc-
tions. Using this more liberal definition, observation was
used for 20.9% of all patients (13.9% no prescription, 7.1%
prescription with wait-and-see instructions) (Table III). If
we examine only the patients with symptoms less than 10
days and without immune suppression, pain, or docu-
mented fever, we find that observation was employed for
34.1% (95/184) of eligible patients (data not shown).
In other words, 69.9% (89/184) of patients with mild
symptoms of short duration were given an antibiotic.
Across all patients, amoxicillin (47.9%) was the
most commonly prescribed antibiotic, followed by azi-
thromycin (19.4%) and trimethoprim/sulfamethoxazole
(16.6%). Among patients treated with antibiotics, 33.6%
were given broad-spectrum therapy (macrolides, fluoro-
quinolones, beta-lactamase inhibitors, and cephalospo-
rins) (Table IV). No patient who was initially managed
without antibiotics received an antibiotic within the sub-
sequent 5 days, and fewer than 1% of patients pre-
scribed antibiotics changed them within 5 days.
On bivariable analysis, we modeled the outcome of
interest as receipt of antibiotics versus observation. We
found that none of the patient demographic characteris-
tics was associated with receipt of antibiotics. Of the
clinical characteristics, symptom duration, facial pres-
sure, rhinorrhea, pain, reported fever, and presumed
TABLE III.
Medical Care Across Adult Acute Sinusitis Visits at UMHS
(N51272).
*Adjunctive Treatment N (%)
Decongestants 512 (40.3)
Nasal steroid sprays 156 (12.3)
Analgesics 142 (11.2)
No adjunctive treatment 613 (48.2)
Antibiotic Treatment N (%)
Antibiotic prescribed 1,005 (79.0)
Wait-and-see prescription for antibiotic 90 (7.1)
No antibiotic 177 (13.9)
*Proportions do not total 100% because some patients were pre-
scribed or advised to use more than one medication.
UMHS5University of Michigan Health System.
TABLE IV.
Antibiotics for Adult Acute Sinusitis at UMHS (N51095).
All Patients No Allergy Penicillin Allergy
Antibiotic N (%) N (%) N (%)
Amoxicillin 524 (47.9) 523 (59.1) 1 (0.5
Azithromycin 212 (19.4) 117 (13.2) 95 (45.2)
Trimethoprim/
sulfamethoxazole
182 (16.6) 112 (12.7) 70 (33.3)
Amoxicillin/clavulanic acid 63 (5.8) 63 (7.1) 0
Fluoroquinolone 54 (4.9) 35 (3.9) 19 (9.1)
Other macrolide 17 (1.6) 8 (0.9) 9 (4.3)
Cephalosporin 21 (1.9) 14 (1.6) 7 (3.3)
Doxycycline 20 (1.8) 12 (1.4) 8 (3.8)
Clindamycin 2 (0.2) 1 (0.1) 1 (0.5)
UMHS5University of Michigan Health System.
TABLE V.
Predictors of Antibiotic Use for Acute Sinusitis, UMHS (N5 1,272).
Variable Unadjusted OR (CI) P Value
Patient Demographics
Age (unit510 years) .99 (0.90–1.10) 0.91
Gender (female vs. male) 1.17 (0.87–1.58) 0.29
Race (nonwhite vs. white)
(n5 1,227)
.90 (0.59–1.38) 0.62
Insurance (public or
uninsured vs. private)
(n5 1,265)
1.15 (0.77–1.72) 0.50
Clinical Variables
Duration
> 10 days vs.<10days 2.15 (1.58–2.94) < 0.001
> 10 days vs.
undocumented
2.59 (1.75–3.83) < 0.001
< 10 days vs.
undocumented
1.2 (0.83–1.74) 0.32
Nasal obstruction 1.28 (0.97–1.70) 0.079
Rhinorrhea 1.50 (1.11–2.01) 0.008
Facial pressure 3.35 (2.50–4.48) < 0.001
Pain 2.78 (2.04–3.79) < 0.001
Reported fever 2.75 (1.79–4.23) < 0.001
Documented fever 1.33 (0.21–8.59) 0.76
Immunocompromised 7.83 (0.42–145.45) 0.17
Trainee present 0.68 (0.46–1.00) 0.052
Etiology
Undocumented vs.
nonbacterial
7.25 (5.24–10.05) < 0.001
Bacterial vs.
undocumented
9.77 (4.79–19.91) < 0.001
Provider Variables
Provider specialty
Internal vs. family medicine 1.89 (1.43–2.49) < 0.001
Emergency vs. family
medicine
8.11 (2.49–26.35) 0.001
Female provider 1.00 (0.76–1.32) 1.00
Years in practice 1.03 (1.01–1.05) 0.007
CI5 confidence interval; OR5odds ratio; UMHS5University of
Michigan Health System.
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etiology were significant predictors of antibiotic use. Of
the provider characteristics, provider specialty and years
in practice were significant predictors of antibiotic use
(Table V). On multivariable analysis of the patient and
clinical characteristics, we found that antibiotic use was
significantly associated with symptom duration longer
than 10 days, facial pressure, pain, reported fever, bacte-
rial or undocumented etiology, and medical trainee (data
now shown).
With multilevel analysis, we found that all of the
patient characteristics from the final multivariable model
remained statistically significant predictors and rhinor-
rhea became significant. Notably, addition of the provider
level covariates was statistically significant in explaining
some of the variation in antibiotic use10 (Table VI).
DISCUSSION
This is the first study with detailed clinical data to
benchmark the quality of care for acute sinusitis against
the AAO–HNS Clinical Practice Guideline: Adult Sinusi-
tis. This is also the first detailed study of provider level
factors associated with antibiotic use. The primary
strength of this article is the study design, which pro-
vided detailed patient and provider information that
allowed us to focus the analysis on patients with newly
diagnosed acute sinusitis.
In this study, we find that symptom duration and
severity influence the decision for antibiotics. We also
find that the visit provider, provider’s medical specialty,
and presence of a medical trainee influence antibiotic
use. Because the diagnosis of acute sinusitis is
TABLE VI.
Summary of Multilevel Regression Analysis for Variables Predicting Receipt of Antibiotics (N5 1272).
Provider Covariates Patient Covariates
Provider and Patient
Covariates (full model) Final Model
Variable Adjusted OR (CI) Adjusted OR (CI) Adjusted OR (CI) Adjusted OR (CI)
Fixed Effects: Level 2 Covariates
Provider specialty
Internal vs. Family medicine 1.80 (1.19–2.74)* 2.56 (1.43–4.57)* 2.57 (1.42–4.66)†
Emergency vs. Family medicine 8.90 (2.45–32.30)‡ 17.7 (3.68–85.09)‡ 18.33(3.87–87.78)‡
Emergency vs. Internal medicine 4.93 (1.36–17.87)* 6.91 (1.44–33.22)† 7.13 (1.52–33.54)†
Female provider 1.20 (0.77–1.88) 1.14 (0.62–2.1)
Years in practice 1.02 (0.99–1.05) 1.03 (0.99–1.07)
Fixed Effects: Level 1 Covariates
Age (unit5 10 years) 0.99 (0.97–1.00) 0.99 (0.97–1.01)
Patient gender (female vs. male) 0.87 (0.57–1.33) 0.88 (0.58–1.34)
Race (nonwhite vs. white) 0.98 (0.52–1.82) 1 (0.54–1.85)
Insurance (public/uninsured vs. private) 1.46 (0.78–2.75) 1.36 (0.72–2.57)
Duration
1 10 days vs.<10 days 1.92 (1.25–2.94)† 1.99 (1.3–3.04)† 2.10 (1.38–3.18)‡
101days vs. undocumented 1.91 (1.1–3.3)* 1.9 (1.11–3.28) * 1.81 (1.05–3.13)*
< 10 days vs. undocumented 1.00 (0.58–1.71) 0.96 (0.56–1.64) 0.86 (0.50–1.49)
Nasal obstruction 1.42 (0.95–2.12) 1.46 (0.98–2.18)
Rhinorrhea 1.9 (1.21–2.97)† 2.01 (1.29–3.14)† 2.74 (1.71–4.39) ‡
Facial pressure 3.52 (2.23–5.58)‡ 3.49 (2.21–5.51)‡ 5.49 (3.30–9.13)‡
Pain 2.54 (1.61–4.02)‡ 2.53 (1.61–4)‡ 2.40 (1.54–3.74)‡
Reported fever 4.19 (2.38–7.37)‡ 4.19 (2.39–7.34)‡ 4.88 (2.76–8.64)‡
Trainee (present vs. absent) 0.39 (0.22–0.71)† 0.33 (0.18–0.59)‡ 0.36 (0.2–0.65) ‡
Etiology
Bacterial vs. undocumented 17.3 (7.03–42.58)‡ 15.95 (6.49–39.19)‡ 19.71 (8.02–48.44) ‡
Bacterial vs. undocumented 1.39 (0.62–3.14) 1.37 (0.61–3.08) 1.52 (0.68–3.43)
Undocumented vs. nonbacterial 12.44 (7.64–20.25)‡ 11.66 (7.20–18.90)‡ 12.94 (8.0–20.93) ‡
Rhinorrhea* Pressure
Rhinorrhea yes (pressure yes vs. no) 1.90 (1.11–3.24)*
Rhinorrhea no (pressure yes vs. no) 15.86 (6.81–6.96)‡
Pressure yes (rhinorrhea yes vs. no) 0.95 (0.53–1.70)
Pressure no (rhinorrhea yes vs. no) 7.91 (3.70–16.94)‡
*P5< .05.
†P5< .01.
‡P5< .001 (two-tailed test).
CI5 confidence interval; OR5odds ratio.
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subjective, and because the use of antibiotics may be
influenced by patient expectations, it is not surprising
that its use varies across providers. However, we did not
expect the magnitude of the effect of individual provider
to be as substantial as it is. In this same vein, the pres-
ence of a medical trainee appears to have a strong pro-
tective effect against antibiotic use for acute sinusitis. It
appears that when a trainee is involved in patient care,
providers are more likely to observe a patient rather
than treat with antibiotics. This appears to be a case of
the Hawthorne effect, mediated by medical students and
residents.11
Consistent with clinical practice guideline (CPG)
statements to assess pain and provide symptom relief,
we find that approximately half of all patients receive
analgesics, decongestants, or nasal steroid sprays.
Despite the CPG recommendation to differentiate viral
from bacterial sinusitis, and the option to observe the
patient with mild bacterial sinusitis without antibiotics,
we find 66% of patients with mild symptoms of short
duration received antibiotics. As recommended by the
CPG, amoxicillin is frequently used as first-line antibi-
otic therapy (48%). Aside from clinical factors, we find
that the medical provider, provider’s specialty, and pres-
ence of a medical trainee significantly impact use of
antibiotics.
The rate of decongestant use that we report is
higher (40% vs. 24%) than previously reported,12 and
analgesic use is lower (11% vs. 19%–23%).13,14 Previous
reports analyzed prospectively collected data to deter-
mine medical treatment, whereas our study design
relied on narrative documentation. As a result, our
study may have underestimated some treatments, par-
ticularly nonprescription therapies that may not be as
well-documented as prescription therapy. This may
explain the lower-than-expected rates of analgesic use
but does not explain the higher-than-expected rates of
decongestant use.12 The proposed explanation of our
finding of high rates of decongestant use is discussed
below.
Overall, antibiotic use in this study was high and
comparable that in other studies (86% vs. 75%–
86%).6,12,13,15 However, the strength of this study is the
clinically detailed nature of our dataset, which allowed
us to examine antibiotic use in a manner that has not
been reported previously. We were able to focus the anal-
ysis on patients with mild symptoms3 and analyze
patients who were given wait-and-see instructions with
the observation group. With this more nuanced analysis,
the frequency of antibiotic use decreases from 86% to
nearly 66%. It is impossible to know what proportion of
patients merit antibiotics versus observation. However,
in light of the self-limiting nature of acute sinusitis, its
high rate of spontaneous resolution, and the large and
growing problem of antibiotic resistance, the frequency
of antibiotic use in this study and in the published liter-
ature is probably too high.16,17
Amoxicillin as a first-line antibiotic was higher
(48% vs. 8%–29%)6,12,13 than previously reported and
broad spectrum antibiotic use was lower (34% vs. 55%–
76%).6,15 The greater use of amoxicillin and lower use of
broad spectrum antibiotics, as well as differential use of
decongestants as mentioned above, likely reflect con-
certed institutional efforts to influence treatment of
acute sinusitis. Those efforts include development of a
local CPG for acute sinusitis.18 The CPG is developed
and regularly updated by a multidisciplinary panel,
including family medicine, internal medicine, and otolar-
yngology clinicians. The CPG recommends decongestants
and amoxicillin but is silent about recommendation of
analgesics. The CPG is promoted through local educa-
tional forums and is available on the institutional home
page of its website with other commonly accessed clinical
care reference for easy access during routine clinical
care. In addition to this educational effort centered on
the CPG, individual providers also received a periodic
profile describing their individual use of antibiotics for
acute sinusitis and a comparison with their peers.
These intensive efforts to modify treatment of acute
sinusitis began in 1995 and thus preceded the 2005 to
2006 time period studied in this thesis. As a result, the
educational and physician profiling efforts may partially
explain the greater use of amoxicillin and decongestants
and the lesser use of analgesics. This is interesting due
to the known difficulty of changing provider behavior
through educational efforts.19–21 Because the current
dataset does not extend prior to 1995, when the institu-
tional intervention began, we do not know how much of
these differences are due to these institutional efforts to
change provider treatment. However, the finding that
some of the marked differences in our study data com-
pared to previously published data correlate with spe-
cific recommendations within our local CPG supports
the value of locally developed and promulgated CPGs.
Study Limitations
This study has significant limitations worth noting.
There are important differences in our study methodol-
ogy compared to studies based on a large cross-sectional
survey such as that available from the National Ambula-
tory Medical Care Survey (NAMCS).6,12–14 Our study
methodology entailed detailed review of clinical docu-
mentation from the patient encounter. To our knowledge,
it is the only study on this topic using such detailed clin-
ical information. Studies using NAMCS data are also
based on diagnostic codes and prescription and nonpre-
scription medication use, but those studies lack impor-
tant clinical information. For example, studies based on
NAMCS are not able to exclude patients who are already
taking an antibiotic, and are not able to discern patients
with newly diagnosed acute sinusitis from those with
recurrent or persistent sinusitis. The longitudinal nature
of the data repository from which we obtained this data-
set and our access to the EMR allowed us to develop a
highly selected dataset with detailed clinical information
in order to gain insight into the pervasive problem of
overuse of antibiotics for acute sinusitis.
Statistics based on administrative data are con-
founded by providers’ biases in their manner of diagnos-
tic coding. For example, one provider may utilize ICD-9
465, “acute upper respiratory infection,” for patients
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with infection whom the provider manages with observa-
tion, and may reserve ICD-9 461, “acute sinusitis,” for
those patients whom the provider treats with antibiotics.
This lack of consistency in diagnostic coding across pro-
viders would result in a nondifferential bias over a large
number of providers. However, in this institutional data-
set with a more limited number of providers, we do not
know the effect of such biases, if indeed they are pres-
ent. If this bias is present, it would contribute to the
amount of variation in antibiotic use attributable to the
individual provider. Also, the results of this study from a
single institution cannot necessarily be generalized to a
wider population.
CONCLUSION
Antibiotics continue to be overused for patients
with mild acute sinusitis of short duration. We report
that nonclinical characteristics, including the medical
provider, the provider’s specialty, and the presence of a
medical trainee, significantly influence use of antibiotics
for acute sinusitis.
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